Back to Search
Start Over
Production and post-surgical modification of VEGF, tPA and PAI-1 in patients with glioma.
- Source :
-
Cancer biology & therapy [Cancer Biol Ther] 2006 Feb; Vol. 5 (2), pp. 204-9. Date of Electronic Publication: 2006 Feb 28. - Publication Year :
- 2006
-
Abstract
- Malignant gliomas are associated with risk of thromboembolism, but the molecular link between tumor and peripheral pro-coagulant status has not been elucidated. Vascular Endothelial Growth Factor (VEGF), tissue-type Plasminogen Activator (tPA), Plasminogen Activator Inhibitor-1 (PAI-1) and lipoprotein (lp) (a) influence the pro-coagulant status. To assess whether the presence of the tumor influenced the peripheral levels of VEGF, tPA, PAI-1 and lp(a), we studied the expression and secretion of VEGF, tPA, PAI-1 and lp(a) in glioma specimens, in peripheral blood and in primary glioma-derived cultures. We also measured lp(a), VEGF, tPA and PAI-1 in the peripheral circulation of patients, before and after surgery for glioma. VEGF, tPA and PAI-1 were expressed in glioma specimens. Glioma cells were indeed a major source of tPA and PAI-1; these molecules were significantly more expressed in glioma than in patient's blood cells. Lp(a) was rarely expressed in glioma specimens and not expressed in blood cells. In glioma, VEGF, tPA and PAI-1 were localized mainly in tumor cells; tPA was localized also in the extracellular matrix and PAI-1 in tumor vascular lumen. Glioma cells were indeed able to produce and release VEGF, tPA and PAI-1. After surgery, peripheral levels of VEGF and PAI-1 were increased, while tPA and lp(a) were unchanged. The great amount of VEGF, tPA and PAI-1 produced by glioma could influence peripheral levels of these molecules. The partial resection of the tumor by surgery was not able to decrease plasma levels of these molecules.
- Subjects :
- Brain Neoplasms complications
Brain Neoplasms surgery
Female
Glioma complications
Glioma surgery
Humans
Male
Middle Aged
Plasminogen Activator Inhibitor 1 blood
Plasminogen Activator Inhibitor 1 genetics
RNA, Messenger analysis
Thrombosis etiology
Tissue Plasminogen Activator blood
Tissue Plasminogen Activator genetics
Vascular Endothelial Growth Factor A blood
Vascular Endothelial Growth Factor A genetics
Brain Neoplasms chemistry
Glioma chemistry
Plasminogen Activator Inhibitor 1 analysis
Thrombosis diagnosis
Tissue Plasminogen Activator analysis
Vascular Endothelial Growth Factor A analysis
Subjects
Details
- Language :
- English
- ISSN :
- 1538-4047
- Volume :
- 5
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Cancer biology & therapy
- Publication Type :
- Academic Journal
- Accession number :
- 16357523
- Full Text :
- https://doi.org/10.4161/cbt.5.2.2357